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The Ca2+-free form of calmodulin (apoCaM) often ap-
pears inert, modulating target molecules only upon
conversion to its Ca2+-bound form. This schema
has appeared to govern voltage-gated Ca2+ chan-
nels, where apoCaM has been considered a dormant
Ca2+ sensor, associated with channels but awaiting
the binding of Ca2+ ions before inhibiting channel
opening to provide vital feedback inhibition. Using
single-molecule measurements of channels and
chemical dimerization to elevate apoCaM, we find
that apoCaM binding on its own markedly upregu-
lates opening, rivaling the strongest forms of modu-
lation. Upon Ca2+ binding to this CaM, inhibition
may simply reverse the initial upregulation. As RNA-
edited and -spliced channel variants show different
affinities for apoCaM, the apoCaM-dependent con-
trol mechanisms may underlie the functional diver-
sity of these variants and explain an elongation
of neuronal action potentials by apoCaM. More
broadly, voltage-gated Na channels adopt this
same modulatory principle. ApoCaM thus imparts
potent and pervasive ion-channel regulation.
INTRODUCTION
Calmodulin (CaM) lacking bound Ca2+ (apocalmodulin, apoCaM)
has often been categorized as less capable of modulating target
molecules, compared to CaM loaded with Ca2+ (Ca2+/CaM)
(Alberts et al., 1994). Certainly, there have been exceptions to
this premise (Jurado et al., 1999), but CaM regulation of ion
channels has seemingly followed the traditional order (Saimi
and Kung, 2002). This study argues to the contrary for voltage-
gated Ca2+ and Na channels.
Among the most salient examples of CaM modulation are
those involving L type (CaV1.3) Ca
2+ channels. These transport
molecules serve as a dominant Ca2+ entry pathway into pace-
making cardiomyocytes and neurons (Bean, 2007) and figure
crucially in rhythmic functions like cardiac pacemaking and mo-608 Cell 159, 608–622, October 23, 2014 ª2014 Elsevier Inc.tor control involving substantia nigra, the prime neurodegenera-
tive locus in Parkinson’s (Chan et al., 2007; Obeso et al., 2008).
As these channels convey substantial Ca2+ entry in these
settings, modulation of CaV1.3 is critical for Ca
2+ signaling and
homeostasis in health and disease (Bean, 2007; Chan et al.,
2007; Puopolo et al., 2007).
One better-studied form of CaV1.3 regulation is the Ca
2+-
dependent inactivation (CDI) of this channel type by CaM (Evans
and Zamponi, 2006). At first glance, the operation of CDI may
now seem simple in coarse outline, at least for the best-studied
CaV1.3 channel variant (Ben-Johny and Yue, 2014). This ‘‘arche-
typical’’ form is distinguished by an IQCaM-binding domain con-
taining the sequence isoleucine-glutamine-aspartate-tyrosine
(IQDY), followed by a stop codon soon after (Figure 1A, variant
0). A single Ca2+-free CaM molecule (apoCaM) first preassoci-
ates with sites including the IQ domain (Figure 1B, configuration
A), thus becoming a resident, but presumably dormant, Ca2+
sensor poised for subsequent channel regulation (Bazzazi
et al., 2013; Ben-Johny et al., 2013; Erickson et al., 2003; Liu
et al., 2010; Pitt et al., 2001). Ca2+ binding to this onboard
apoCaM then sharply reduces channel open probability (PO)
(Figure 1B, configuration I) (Ben-Johny et al., 2013), furnishing
Ca2+-negative feedback crucial for Ca2+ handling. Channels
without apoCaM cannot undergo CDI (Bazzazi et al., 2013;
Ben-Johny et al., 2013; Liu et al., 2010).
That said, the full reality of the modulatory landscape is stag-
gering in its complexity, given recent discoveries of a prominent
array of RNA-edited and splice variants of CaV1.3 (rest of Fig-
ure 1A). RNA editing yields different sequences in the IQ element
(Huang et al., 2012), and alternative splicing produces channels
with conspicuous extensions after the IQ domain (Bock et al.,
2011; Hui et al., 1991; Tan et al., 2011; Xu and Lipscombe,
2001). These newly recognized variants actually constitute the
bulk of CaV1.3 channels in the brain, and they exhibit vast differ-
ences in CDI (Bazzazi et al., 2013; Bock et al., 2011; Huang et al.,
2012; Tan et al., 2011), projecting this diversity as an extensive
but largely unexplored system for tuning Ca2+ dynamics. But
CDI tuningmay only foreshadow a larger mysterious effect—het-
erologous expression of CaV1.3 variants frequently exhibits
sharply diminished current densities that seem too prominent
to attribute to happenstance (Bazzazi et al., 2013; Bock et al.,
2011; Huang et al., 2012; Tan et al., 2011). Could a major
Figure 1. CaM Alters PO of L Type Channel Variants at Single-Molecule Level
(A) CaV1.3 channel carboxy-tail variation by alternative splicing and RNA editing. Cyan, blue, red, and green symbols correspond, respectively, to references
Huang et al., 2012; Hui et al., 1991; Tan et al., 2011; and Bock et al., 2011.
(B) Configuration A (active), channels (shown as gray circles) bound to apoCaM (shown as two lobes and linker) have high baseline PO (PA). Configuration I
(inactivated), channels bound to Ca2+-CaM have diminished channel PO (PI) (Ben-Johny et al., 2013; Imredy and Yue, 1994).
(C) Hypothetical fixed and idiosyncratic CDI and baseline PO profiles for CaV1.3 variants.
(D–G) Single-channel analysis of four recombinant CaV1.3 variants transiently expressed in HEK293 cells with only endogenous CaM present. Top subpanels,
unitary Ba2+ currents during voltage ramp, shown between50mV and +40mV (slanted gray lines, GHK fit). Bottom subpanel, average single-channel PO versus
voltage.
(H–K) Single-channel records under elevated apoCaM. Light gray line reproduced from corresponding variant above.
All averages derived from multiple patches (n = 4–6). Error bars are ± SEM throughout. Behaviors shown for CaV1.3S (Extended Experimental Procedures for
detailed sequence) in (A) and (D) were indistinguishable in this regard to those for a closely similar natural splice variant CaV1.342A (Xu and Lipscombe, 2001) (not
shown).unsuspected action of CaV1.3 variation be to adjust baseline
channel PO, thereby producing an equally large or greater effect
on Ca2+ signaling than CDI? Figure 1C cartoons the potentialarray of channel behaviors that would then result, where each hy-
pothetical Ca2+ current trace portrays the functional profile of an
individual variant. Whether such PO effects actually exist acrossCell 159, 608–622, October 23, 2014 ª2014 Elsevier Inc. 609
variants and whether their mechanistic underpinnings relate to
CDI remain open and difficult questions that cloud the physi-
ology and pharmacological manipulation of CaV1.3 variant chan-
nels in relation to Ca2+ signaling and dysregulation.
Here, we exploit single-molecule and chemical-biological ap-
proaches to reveal a simple principle thatmay unify the spectrum
of CaV1.3 molecular variants. In particular, we combine chemi-
cal-dimerizer-driven step increases in plasmalemmal CaM with
simultaneous electrophysiological readouts of channel function
(Luik et al., 2008; Spencer et al., 1993; Suh et al., 2006). We
thus reveal that the binding of a single apoCaM to channels
does considerably more than permit CDI to occur. ApoCaM
binding itself also enhances channel opening (PO) by several
fold, rivaling the strongest forms of channel modulation (Miriyala
et al., 2008). RNA editing, alternative splicing, and fluctuating
CaM levels thus regulate CDI and baseline PO, acting to variably
populate pools of channels lacking or bound to apoCaM.
A key prediction is that elevated CaM should boost CaV1.3
opening and prolong neuronal action potentials. Indeed, we
explicitly demonstrate this outcome in substantia nigral neurons.
More broadly, a recent study reveals notable similarity between
the Ca2+/CaM regulation of CaV channels and that of voltage-
gatedNaV channels (Ben-Johny et al., 2014). Here, we generalize
this likeness, showing that apoCaMbinding to NaV channels also
strongly amplifies PO. Thus, apoCaM imparts a potent and
pervasive form of ion-channel regulation, whose implications
range as far as the sweep of CaV and NaV superfamilies, and
perhaps beyond (Saimi and Kung, 2002).
RESULTS
CaM Modulates Baseline Opening of L Type Channels
We first tested whether the baseline PO of certain variant chan-
nels is in fact diminished, and whether CaM at all influences
this PO. Figure 1D displays the properties of the canonical
CaV1.3 ‘‘short’’ splice variant (CaV1.3S, Figure 1A, variant ‘‘0’’),
with the IQ domain translated as amino acids IQDY (as coded
by genomic sequence). We used low-noise electrophysiology
(Tay et al., 2012) to directly observe single-channel PO and em-
ployed Ba2+ as the charge carrier through channels because
Ba2+ binds poorly to CaM (Chao et al., 1984). This maneuver
would thus preclude entry into configuration I (Figure 1B), allow-
ing alterations in baseline PO to be observed apart from CDI.
Accordingly, a slow voltage ramp (shown from 50 to +40 mV)
elicits stochastic openings that reflect near steady-state PO at
each voltage. The top rows display stochastic records, where
channel closures correspond to the zero-current portions of
the trace (on horizontal gray lines) and openings to downward
deflections to the open level (slanted gray curves). Averaging
many records yields a mean current that can be divided into
the open level (slanted gray curve) to furnish the PO versus
voltage relation (sigmoidal trace at bottom), averaged over mul-
tiple patches.
Thus apprised, we examined the single-molecule properties of
a prominently expressed CaV1.3 ‘‘long’’ splice variant (variant 5 in
Figure 1A), featuring an extended distal carboxyl tail (DCT) as
schematized atop Figure 1E. For convenience, we will refer to
this variant as CaV1.3L. Scrutiny of the single-trial records and610 Cell 159, 608–622, October 23, 2014 ª2014 Elsevier Inc.PO-V relation for this variant indeed reveals a far lower PO. Inter-
estingly, the presence of aDCT is not required for a diminishedPO
because Figure 1F shows that a common RNA-edited variant
within a short-splice configuration (variant 1 in Figure 1A, or
CaV1.3S/MQDY) also displays attenuated PO compared to the ca-
nonical CaV1.3S. Curiously, both CaV1.3L and CaV1.3S/MQDY
exhibit diminished apoCaM binding affinity (Bazzazi et al., 2013;
Liu et al., 2010). Thus, we tested for PO effects in a man-made
variant, where apoCaMaffinity has been attenuated bymutations
in the carboxyl tail of CaV1.3S (CaV1.3S/TVM-AAA, cartooned atop
Figure 1G) (Ben-Johny et al., 2013). CaV1.3S/TVM-AAA also exhibits
reduced PO (Figure 1G).
Given this pattern, we tested more directly for the involvement
of apoCaM inmodulating PO, by strongly overexpressing recom-
binant CaM with these same constructs. Perhaps, PO might be
upregulated by apoCaMoccupancy of some site, so that overex-
pressing CaM may boost occupancy by mass action. For the
prototypic short variant CaV1.3S, no such enhancement of PO
is produced by CaM overexpression (Figure 1H), as if the hypo-
thetical site were already bound to CaM at baseline. By contrast,
elevated CaM produces an impressive increase of PO in all other
constructs with diminished apoCaM affinity (Figures 1I–1K),
where an appreciable fraction of channels might initially lack
indwelling CaM.
Single-Channel PO Modulated in Quantized Manner
However, overexpressing recombinant CaM could enhance
channel PO by a multitude of mechanisms besides binding to a
channel modulatory site. For example, CaM-dependent modula-
tion of various kinases and phosphatases or even gene regulation
of auxiliary factors could be in play (Bers and Grandi, 2009). To
garner further mechanistic constraints, we considered a distinc-
tive feature of an apoCaM-binding model, as diagrammed atop
Figure 2A. Here, beyond the configuration A described earlier,
we explicitly hypothesize a configuration lacking apoCaM at a
POmodulatory site (configuration E). In this formulation, channels
bound to apoCaM (configuration A) would open with a high PO as
exemplified by CaV1.3S (Figure 1D), and those lacking apoCaM
would exhibit low PO. A hallmark feature of this paradigm is that
channel PO should be quantized, manifesting as a high PO
‘‘mode of channel gating’’ when apoCaM is bound (Hess et al.,
1984) or a low PO mode when apoCaM is absent. By contrast,
many other mechanisms (e.g., multiple phosphorylation sites)
could produce a graded spectrum of intermediate effects. These
contrasts might be abundantly clear at the single-channel level.
Figure 2A displays twelve sequential single-channel trials of
the RNA-editing variant CaV1.3S/MQDY with only endogenous
CaM present. Activity was evoked by voltage ramps introduced
at 12 s intervals. The activity appears uniformly sparse, as
confirmed by the diary plot of average PO within individual trials
(PO, Figure 2B), as well as the single bell-shaped distribution of
PO drawn from a larger set of trials (Figure 2D). These results
are consistent with a channel residing almost exclusively within
a hypothesized configuration E. The corresponding average
PO-V relation (Figure 2C) may thus pertain to channels residing
in configuration E alone.
By contrast, upon strongly coexpressing recombinant CaM
with another CaV1.3S/MQDY channel (Figures 2E–2H), activity is
Figure 2. Single-Channel PO Modulated by CaM in Quantized Manner
(A) CaV1.3S/MQDY in HEK cells with only endogenous CaM present; mainly expected to occupy configuration E (top cartoon). Single-channel Ba
2+ currents during
voltage ramp, shown between 40 and +40 mV, elicited at 12 s intervals.
(B) For each current trace in (A), averagePO between30 and +25mV (PO (30% V% 25)) was calculated. Traces categorized into low PO (red-shaded) region or
high PO range (gray-shaded).
(C) Average PO at each voltage, calculated separately for traces in low PO (red) versus high PO range (gray). In this case, all traces are in low PO group (red).
(D) Number of sweeps with PO (30% V% 25) within indicated PO ranges. Histogram fits with unimodal distribution (p > 0.9) by Hartigan’s dip test (Extended
Experimental Procedures).
(E–H) Same analysis for CaV1.3S/MQDY with CaM overexpression. (H) PO histogram unlikely to be unimodal (p < 0.05, Hartigan’s dip test), thus fit by bimodal
distribution.
See also Figures S1 and S2.
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markedly enhanced in a conspicuously quantized manner.
Although many trials exhibit a high PO pattern of gating (Fig-
ure 2E, trials 1, 3, 5–8, 10, 12), low PO trials resembling those
without apoCaM overexpression (Figure 2A) are clearly inter-
spersed (Figure 2E, trials 2, 4, 9, 11). This apparent quantization
of high and low PO gating is confirmed by the segregation of PO
into distinct zones in the diary plot (Figure 2F) and by the bimodal
distribution of PO amassed from a large number of trials (Fig-
ure 2H). Little intermediate activity can be discerned. These
data are thus consistent with channel switching between
discrete E and A configurations. By grouping trials into high
and low PO groups with the dashed-line discriminator in Fig-
ure 2F, we could estimate separate PO-V relations for each
gating mode (Figure 2G). Notably, the low PO-V relation (red) is
fit by the same function used without elevating apoCaM (Fig-
ure 2C), arguing for the invariance of configuration E between
conditions. Also notable is the 7-fold enhancement of high
versus low PO-V relations, suggesting an enormous effect of
apoCaM on channel opening. Parallel experiments with other
CaV1.3 variant channels (CaV1.3S, CaV1.3L, CaV1.3S/TVM-AAA)
confirmed similar quantized behavior (Figures S1 and S2).
ApoCaM Binding to CDI Site Correlates with Enhanced
Baseline PO
The digital manner by which apoCaM enhances baseline PO fits
well with a simple apoCaM-binding mechanism (top of Figure 2).
Nonetheless, other plausible mechanisms could also elaborate
quantized behavior, such as phosphorylation and dephosphory-
lation at a single site. To begin to discriminate among these pos-
sibilities, we noted that a direct CaM-binding mechanism for PO
modulation (Figure 3A) would predict a simple Langmuir relation
between the peak PO measured with only endogenous apoCaM
present (PCaM/endo) and the association constant for apoCaM
binding to a presumed PO modulatory site (Ka). Figure S3 yields:
PCaM=endo =PE + ðPA  PEÞ,Ka=ðKa +LÞ (1)
where PE is the open probability of channels lacking apoCaM
(Figure 3A, configuration E), PA the open probability of channels
prebound to apoCaM (configurationA), andLf [apoCaMbulk]
1.
The challenge with applying tests based on this equation was
the unknown identity of the hypothetical apoCaM-binding site
for PO modulation, much less the corresponding Ka for various
CaV1.3 variants. Indeed, atomic structures of Ca
2+/CaM com-
plexedwith carboxy-tail peptides of closely related CaV1.2 chan-
nels argue for the binding of multiple CaM molecules per tail,
each bound CaM imparting a different function (Fallon et al.,
2009; Kim et al., 2010). That said, we conjectured that theFigure 3. ApoCaM Affinity Tunes PO
(A) Proposal that channel apoCaM affinity (Ka) specifies equilibrium between con
(B) Plot of peak PO obtained with only endogenous CaM present (PCaM/endo) versus
channel carboxyl termini and apoCaM (Figure S3 and Table S1). Error bars are ±
(C) Average PO (format as in Figures 1E–1L) for recombinant CaV1.3S channels wit
CaV1.3S (Figure 1E) for comparison. All averages from multiple patches (n = 3–6
(D) Phase-plane signature of single-CaM behavior during CaM transients.
(E) Two-CaM behavior during CaM transients, revealed by phase-plane paradigm
See also Figure S4.apoCaM-binding site for PO modulation might be one and the
same as the site involved in the CDI process (Figure 1B). Else-
where, we have previously determined theKa values for apoCaM
binding to the carboxy-tail site relating to CDI, not only for the
CaV1.3 variants in Figures 1E–1H but also for additional variants
whose PO profiles are characterized in Figure 3C (Bazzazi et al.,
2013; Ben-Johny et al., 2013; Liu et al., 2010). Plotting PCaM/endo
versus Ka for all of these variants in Figure 3B then tests for the
prediction of Equation 1. It is noteworthy how well the data sym-
bols fit with the Langmuir function (smooth curve) in Figure 3B,
an outcome consistent with the binding of one and the same
apoCaM modulating both PO and the ability to undergo CDI.
For robustness, open probabilities were measured at maximal
depolarization for the plot in Figure 3B.
Rapid Plasmalemmal Recruitment of ApoCaM Triggers
Dual Modulation of PO and CDI
Nonetheless, the suggestive correlation in Figure 3B requires
compilation of data from several variants, characterized over
multiple cells by differing techniques. By contrast, a consider-
ably more direct test would arise if we could abruptly change
the free apoCaM concentration at the cytoplasmic face of chan-
nels, all while performing electrophysiology within individual
cells. The result would be revealing because the evolving values
of CDI and PO thus observed would adhere to a specific
moment-to-moment interrelation if the one-apoCaMmechanism
conjectured above were to hold true. This can be seen as follows
in Figure 3D. The top subpanel portrays a hypothetical step-like
increase in the free apoCaM concentration facing channels. This
‘‘input’’ would drive a scheme in which channel binding to a sin-
gle apoCaM imparts a shift from configurations E to A, defined
such that channels in E are incapable of undergoing CDI and
exhibit a low PO (PE), whereas those in A demonstrate a robust
CDI and a high PO (PA) before undergoing CDI. The following
linear relation must then hold for a mixed population of channels,
such as observed in whole-cell recordings (Figure S4),
Ipeak

Imax =PE,ð1 CDIÞ1; (2)
where Ipeak is the peak Ca
2+ current before CDI onset; Imax is the
current amplitude if all channels in a cell were simultaneously
open; CDI is the CDI metric defined in Figure 1C; and PE is the
open probability of channels in configuration E ( = 0.051 from Fig-
ure 3C). In this relation, (1CDI)1 may be considered a linear-
ized CDI metric, starting at one whenCDI is absent, and growing
larger as CDI intensifies. As well, Ipeak / Imax turns out to be the
average peak open probability of all channels in a cell before
CDI onset, referred to as Ppeak. That said, the thin black line infigurations E (low PO) and A (high PO).
previously estimated association constants gauged by live-cell FRET between
SEM.
h variant carboxyl tails yielding reduced apoCaM affinity. Gray lines from basic
). Error bars are ± SEM.
.
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the bottom subpanel of Figure 3D explicitly plots Equation 2.
Here, a key feature concerns the immutable interrelation be-
tween Ppeak and (1CDI)1, even during an abrupt increase of
apoCaM. Even though apoCaM binding to channels would
deviate from equilibrium during such a transition, all Ppeak versus
(1CDI)1 points would nonetheless reside on the same line
(thick black arrow trajectory). This feature arises because each
point on the trajectory corresponds to a specific fraction of chan-
nels bound to apoCaM, and each fraction enforces a unique pair-
ing of Ppeak versus (1CDI)1 values. In this scheme, then, there
are no arrangements that fall outside this regime.
By contrast, if the enhancement of baseline PO were governed
by a separate process other than the apoCaM binding that arms
channels for CDI, deviation from the linear relation in Figure 3D
would likely occur. For concreteness, consider a system where
apoCaM binding to one site enables CDI to proceed (Figure 3E,
middle subpanel, configurations within magenta zone), but
apoCaM binding to an alternative site (yielding configurations
in yellow zone) increases baseline PO before CDI onset, from
PE to PA. For simplicity, apoCaM binding to these sites is
assumed to occur independently, and the steady-state fraction
of peak current remaining after CDI is set to reproduce the exper-
imentally observed CDI in CaV1.3S (Ben-Johny et al., 2013). If the
dissociation constants for apoCaM binding to PO (KdjP) and CDI
(KdjCDI) sites were equivalent, then the two-CaM scheme would
predict the downwardly convex relation between Ppeak and
(1CDI)1 (Figure 3E, curve a in bottom subpanel), contrasting
with the linear relation for the one-CaM scheme. However, if
KdjCDI were precisely equal to KdjP , PE / PA, then the two-CaM
scheme would still enforce the linear relation in the bottom sub-
panel of Figure 3E (curve b) at steady state, where this line would
be identical to that for the one-CaM scheme (Figure S4). How-
ever, even here, the difference in dissociation constants at the
two sites means that the transient response to abrupt changes
in apoCaM would deviate from the linear steady-state relation;
this outcome is demonstrated by the numerically simulated hys-
teretic trajectories in Figure 3E (red), where the CDI regulatory
site loads at the same rate or faster than the PO site as marked
(Figure S4). In sum, this manner of analysis relating to abrupt
changes in apoCaM furnishes powerful means to distinguish
among differing mechanisms. Likewise, other potential PO mo-
dulatory mechanisms, like channel phosphorylation, would pre-
dict analogous deviations from linearity (Equation 2), particularly
during abrupt increases in apoCaM.
We therefore exploited chemical-biological step generation
of apoCaM concentration at the cytoplasmic face of chan-
nels, based on rapamycin-triggered dimerization of cytoplasmic
FK506-binding protein (FKBP) and the FKBP-rapamycin-binding
protein (FRB) localized to plasmalemma by a signal sequence
from Lyn kinase (Lyn-FRB) (Phua et al., 2012). Figure 4A cartoons
the layout, where bath-applied rapamycin should sharply in-
crease perimembranous apoCaM, as confirmed by confocal
microscopy visualizing the FKBP–CaM moiety (Figure 4B, top).
Line-histogram analysis reveals a 6-fold increase of perimem-
branous CaM with t 20 s (Suh et al., 2006) (Figure 4B, bottom).
Hence, coexpressing CaV1.3 variants in this context would
permit electrophysiological readouts of PO and CDI during pe-
riods of rapidly increasing apoCaM.614 Cell 159, 608–622, October 23, 2014 ª2014 Elsevier Inc.CaV1.3S serves as a control (Figure 4C). Because of its high
apoCaMaffinity at theCDI site, most channels heremight already
be charged with apoCaM at baseline, such that increasing
apoCaM with rapamycin should produce negligible change.
The top two rows display diary plots of peak current and CDI
measured from Ca2+ currents evoked every 20 s by 30 mV step
depolarizations, with corresponding current waveforms shown
below. The baseline PO of channels is proportional to peak cur-
rent, which is displayed in a normalized format (Ipeak / IO, as
defined below) to facilitate averaging across cells. The metric of
CDI (CDI) is specified by ID / Ipeak, with these measures also
diagrammed below. As expected, augmentation of apoCaMcon-
centration by rapamycin negligibly perturbed either metric.
By contrast, for an RNA-edited variant (CaV1.3S/MQDY) with
moderate apoCaM affinity, a markedly different outcome arises
(Figure 4D). Here, rapamycin-induced CaM enrichment causes
a hand-in-hand increase of peak current and CDI, clearly evident
in exemplar traces on the bottom. These trends are entirely
corroborated by averaged diary plots above (green circles, top
and middle rows). Similarly, parallel increases in peak current
and CDI were observed for two other variants featuring reduced
aggregate apoCaM affinity (Figures 4E and 4F), each with
distinctive response kinetics to the step increase of apoCaM.
As a control, parallel experiments performed without CaM fused
to FKBP invariably showed no changes in either peak current or
CDI upon application of rapamycin, verifying that the observed
effects were due to CaM enrichment and not FKBP itself (Fig-
ure S5). Also, current densities for variants predicted to lack
apoCaM at baseline (Figures 4D–4F) were on average smaller
than for CaV1.3S (Figure 4C), as would be expected if PO were
diminished without bound apoCaM (Figure S5E). Finally, recruit-
ing a CaMmutant unable to bind Ca2+ (CaM1234), and using Ba
2+
as the charge carrier, provided further evidence that apoCaM
is in fact responsible for the observed enhancement in PO
(Figure S6).
One CaM Augments Baseline PO and Enables CDI
With these well-behaved transient responses in hand, we under-
took mechanistic analysis relating to moment-to-moment plots
of Ppeak versus (1CDI)1. Figure 5A renders as dark green sym-
bols the data from the exemplar cell in Figure 4D (CaV1.3S/MQDY),
with explicit labeling of points (i, ii, and iii) corresponding
to exemplar currents shown earlier. The only free parameter is
Imax in Equation 2, which was adjusted only to vertically
normalize the data. Accordingly, the observed linearity and cor-
respondence to predicted slope PE is intrinsic to the data set.
Therefore, adherence of these data points, and those from addi-
tional cells (pale green symbols), to the one-CaM relation
throughout the CaM step is significant. Applying the same anal-
ysis to data from the exemplar cell in Figure 4E (CaV1.3L) also
demonstrates strict conformity to the same linear relation, even
with numerous points drawn from the transient phase of the
response (Figure 5B, dark blue symbols). Points from other cells
(pale blue symbols) also adhere nicely to the same relation. Data
for the exemplar cell relating to still another variant (Figure 4F,
CaV1.3S/1.4DCT) also reside on the same line (Figure 5C, dark
red symbols), and additional cells also conformed to the same
line (pale red symbols). Finally, Figure 5D overlays all these
Figure 4. Step Increases in CaM Rapidly Modulate Both Peak Current and CDI
(A) Recombinant channels in HEK293 cells with both membrane-localized GFP-tagged FRB and cytosolic RFP/YFP-tagged FKBP fused to wild-type CaM.
(B) Top, confocal image of RFP/FKBP/CaM translocation to plasma membrane on 200 nM rapamycin perfusion. Bottom, time course of RFP membrane fraction
measured every 20 s (n = 7 cells).
(C) Diary of normalized peak current (top subpanel) and CDI (middle subpanel) from whole-cell Ca2+ currents through CaV1.3S channels, evoked at 20 s intervals
by steps to +30 mV from 90 mV holding potential. Corresponding current waveforms below.
(D–F)Normalizedpeakcurrent andCDI forCaV1.3 variantswith reducedapoCaMaffinity. Format as in (C).Gray fit of apoCaMrecruitment toplasmalemma from (B).
All peak current and CDI measures obtained from multiple cells (n = 4–8). Error bars are ± SEM in (B)–(F). See also Figures S5 and S6.
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Figure 5. Phase-Plane Analysis Indicates
that One CaM Modulates Both PO and CDI
(A) Dark green symbols for exemplar cell in Fig-
ure 4D (CaV1.3S/MQDY), with labeled points (i, ii, and
iii) corresponding to exemplar currents in Fig-
ure 4D. Pale green symbols, data from additional
cells expressing CaV1.3S/MQDY.
(B and C) Same analysis for exemplar cells in Fig-
ure 4E (CaV1.3L, dark blue symbols) and Figure 4F
(CaV1.3S/1.4DCT, dark red symbols), respectively.
Pale symbols, data from additional cells.
(D) Data from additional cells for each variant and
for a further canonical CaV1.3S variant (dark gray
symbols) (n = 23 cells).
(E) One-apoCaM mechanism unifies diversity of
baseline PO and CDI properties of CaV1.3 variants.
(F) Simulation of PO–CDI coordination with free
apoCaM concentration for a single CaV1.3 variant.data, and those of another variant (gray symbols, CaV1.3S), thus
arguing strongly for compliance with a single linear relation. On
this basis, we propose the simple one-apoCaM mechanism in
Figure 5E, which may unify the diversity of baseline PO and
CDI properties of numerous variants (Figure 1A). RNA-editing
and splice variants modulate PO and CDI over a large range,
largely by tuning the affinity of apoCaM binding to channels
(in configuration E), rather than by specialized molecular mech-
anisms particular to each variant. Fluctuations in ambient
apoCaM could also tune CaV1.3 as shown in Figure 5F. Two
realms of generalization immediately follow.616 Cell 159, 608–622, October 23, 2014 ª2014 Elsevier Inc.Predicted Neuronal Action
Potential Elongation
The strong upregulation of CaV1.3 chan-
nel PO by apoCaM promises signifi-
cant consequences, particularly where
CaV1.3 channels contribute prominently
to pacemaking, such as in the substantia
nigral neurons modulating movement
control (Chan et al., 2007; Christel et al.,
2012; Obeso et al., 2008). Importantly,
elevated Ca2+ in dopaminergic neurons
in the substantia nigra pars compacta
(SNc) predisposes for neurodegeneration
in Parkinson’s disease (Bezprozvanny,
2009). CaV1.3 channels here support the
bulk of Ca2+ entry (Bean, 2007; Cardozo
and Bean, 1995; Chan et al., 2007;
Puopolo et al., 2007), and Ca2+ channel
activity shapes action potential (AP)
morphology (Nedergaard, 1999; Puopolo
et al., 2007). These neurons express a
variety of CaV1.3 splice and RNA-edited
variants as shown in Figure 1A (Bock
et al., 2011; Huang et al., 2012), and
elevating CaM in these cells drives CaM
onto low-affinity channel variants by
mass action (Bazzazi et al., 2013). Numer-
ical simulations described below predictthat apoCaM enhancement of CaV1.3 opening should produce
telling changes in action-potential morphology, which we tested
for experimentally as follows.
SNc dopaminergic neurons were dissected from transgenic
mice selectively expressing GFP under the tyrosine hydroxylase
(TH) promoter, enabling robust identification via fluorescence
(Figure 6A, left subpanel). After culture for 1–7 days, cells main-
tained typical autonomous pacing at 1.0 ± 0.03 Hz (middle sub-
panel) and AP morphology (right subpanel) (Chan et al., 2007;
Grace and Bunney, 1984; Puopolo et al., 2007). The AP duration
at 90% of baseline (APD90) was 7.4 ± 0.03 ms, as expected from
Figure 6. Predicted AP Elongation in Neurons
(A) Confocal image of cultured mouse substantia nigra (pars compacta) dopamine neuron (left subpanel). Middle subpanel, representative current-clamp
recording of pacing in a SNc DA neuron in culture. Right subpanel, characteristic AP waveform obtained by averaging 2,100 APs.
(B) Quantitative in silico model (left subpanel). Numerical simulations of pacing (middle subpanel) and AP morphology (right subpanel) are shown.
(C) Simulated AP waveforms with fraction of CaV1.3 channels bound to apoCaM equal to 0.3 (gray), compared to fraction bound of unity (red). Top subpanel, raw
waveforms; bottom subpanel, normalized waveforms. See Extended Experimental Procedures and Table S2.
(D) Average AP from cultured SNc DA neurons before (black trace), and after applying Bay K8644 (5 mM) (blue trace) (n > 620 APs).
(E) AP recorded in SNc DA neurons with only endogenous CaM present (black trace) and with CaM overexpression (red trace) (n > 800 APs).
All APs measured from n = 4–5 cells. SEM shown as shading in (D) and (E).prior reports (Puopolo et al., 2007). To predict the effects of
apoCaM-driven PO enhancement on AP morphology, we per-
formed in silico simulations with a model (Chan et al., 2007) that
closely recapitulated the firing pattern and AP morphology of
these cultured neurons (Figure 6B) (Extended Experimental Pro-
cedures). Upon increasing the fraction of CaV1.3 channels bound
toCaMby 3-fold, simulated APwaveforms elongate dramatically
from the gray baseline trace to the red waveform (Figure 6C). The
top subpanel displays raw waveforms, and the bottom subpanel
normalizes these responses to facilitate visual comparison of du-
rations. Current-clamp records in cultured neurons confirmed
that enhancement of L type channel PO by Bay K8644 induced
similar AP prolongation, with APD90 increasing from 4.9 ± 0.92
to 11.5 ± 1.55 ms (Figure 6D). The key test came with lentiviral-
mediated overexpression of wild-type CaM, yielding a striking in-
crease of APD90 from 7.4 ± 0.03 ms with endogenous CaM to24.3 ± 0.40 ms on overexpressing CaM (Figure 6E). Thus, fluctu-
ations of apoCaM could alter AP morphology in substantia nigra
and elsewhere in the brain (Bazzazi et al., 2013).
ApoCaM PO Modulation Extends to NaV Channels
The marked apoCaM modulation of CaV1.3 gave reason to
wonder whether this scheme might generalize to other ion chan-
nels. In particular, voltage-gated Na channels (NaV) have recently
been shown to exhibit CaM-mediated CDI that appears remark-
ably similar to that in CaV channels (Ben-Johny et al., 2014).
Moreover, earlier experiments report that apoCaM binds the
carboxyl tail of NaV channels (Herzog et al., 2003), an interaction
confirmed in Figure S7. Given the extensive role of NaV channels
in fast electrical conduction within brain, heart, andmuscle (Hille,
1984), we tested for apoCaM modulatory effects in NaV chan-
nels. As alanine substitutions in the IQ domain of skeletal muscleCell 159, 608–622, October 23, 2014 ª2014 Elsevier Inc. 617
(legend on next page)
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NaV1.4 channels have been shown to both reduce CaM binding
and decrease current density (Herzog et al., 2003), we undertook
direct single-molecule POmeasurements on this particular chan-
nel isoform.
To test for apoCaMmodulatory effects, we compared the sin-
gle-channel activity of wild-type NaV1.4 (which avidly binds
apoCaM at baseline) with that of a mutant NaV1.4IQ/AA exhibiting
weakened apoCaM affinity via IQ to AA substitution within the IQ
domain (Figure S7). Wild-type recombinant NaV1.4 channels ex-
hibited frequent stochastic openings of millisecond duration
(Figure 7A). Normalizing the ensemble average of many such re-
cords (by unitary current i and number of channels N) yields a
robust PO waveform that peaks at 0.5 (Figure 7B). This outcome
is confirmedby plots of peakPO versus step potential (Figure 7C),
averaged from multiple patches. By contrast, NaV1.4IQ/AA
channels might often lack apoCaM at baseline. Fitting with a
mechanism where such channels would be reluctant to open,
corresponding single-molecule records display a sparser pat-
tern of activity with briefer openings (Figure 7D). The ensemble
average explicitly confirms this impression, yielding a diminutive
PO waveform (Figure 7E) and PO–V relation (Figure 7F). Still, this
reduced opening could be an intrinsic effect of mutation, rather
than of lacking apoCaM. To exclude the former possibility, we
strongly coexpressed CaM with NaV1.4IQ/AA channels, a maneu-
ver that should restore apoCaM binding via mass action. Reas-
suringly, corresponding single-molecule records again exhibit
robust activity (Figure 7G), and peak PO is rescued to near
wild-type levels (Figures 7H and 7I), confirming a primary action
of apoCaM to elevate PO. These data therefore support conser-
vation of apoCaMmodulation of PO in both CaV and NaV channel
superfamilies. As such, like the arrangement for CaV1.3 chan-
nels, we propose that NaV1.4 channels have the potential to
reside within one of three configurations (Figure 7J): low PO
configuration E lacking apoCaM; high PO configuration A bound
to apoCaM; and low PO configuration I bound to Ca
2+/CaM.
Each configuration may elaborate distinct Na currents upon
step depolarization (Figure 7J, bottom subpanels).
DISCUSSION
Apocalmodulin has been traditionally viewed as playing a
secondary role to Ca2+/calmodulin for effectuating molecular
function (Alberts et al., 1994). More recently, however, there
has been growing awareness that apoCaM serves many roles
(Jurado et al., 1999). Here, we reveal that apoCaM itself promi-
nently regulates both voltage-gated Ca2+ and Na channels.Figure 7. ApoCaM Modulates PO of NaV1.4 Channels
(A) Single-molecule records of wild-type NaV1.4 channels transiently expressed
(B) PO waveform obtained by normalizing ensemble average of >100 records by
(C) Plot of peak PO versus step potential (from 90 mV holding potential), averag
(D) Single-channel records for NaV1.4 channels containing IQ to AA substitution
minimize free CaM levels (Liu et al., 2010).
(E and F) Corresponding PO waveform (E) and PO–V relation (F). See also Figure
(G) Single-channel traces for NaV1.4IQ/AA paired with overexpressed CaM.
(H and I) Corresponding PO waveform (H) and PO–V relation (I) both restored to n
bars, SEM.
(J) Top, proposed NaV configurations with respect to CaM. Bottom, simulated NApoCaM binding to these channels enhances opening several-
fold, matching the strongest forms of ion-channel regulation.
This effect may unify understanding of a vast array of channel
variants and channelopathic mutations that modulate channel
affinity for apoCaM. New avenues are thus opened for under-
standing and manipulating related diseases.
Before turning to broader ramifications, two enabling method-
ological advancesmerit attention. First, low-noise single-channel
measurements permit direct observation of quantized regulatory
phenomena (Figure 2), crucial to deducing mechanism. Second,
chemical-dimerizer-based step generation of perimembrane
CaM furnishes powerful means to observe CaM-regulatory
events in real time within single cells, excluding ambiguities of
data drawn from multiple cells and methods. Importantly, a prior
strategy for elevating perimembranousCaM requires kinase acti-
vation (Yang et al., 2013), potentially complicating discernment
of CaM-specific actions. Moreover, our study illustrates the
capability of a step generator to resolve biological signal bifurca-
tion upon the binding of a single molecule (apoCaM imparting
both an immediate boost inPO and subsequent CDI); suchmech-
anisms are difficult to prove by customary steady-statemethods.
Indeed, the overall approach (Figure 3D) mirrors the phase-plane
analysis of electronics, highlighting synergy between biological
and electrical network analysis (Jack et al., 1975). Biological
signal generators and analysis, based not only on perfusable li-
gands (Spencer et al., 1993) but also on light activation (Hahn
and Kuhlman, 2010; Kennedy et al., 2010; Yazawa et al., 2009),
may aid future understanding of other signaling systems.
Mechanistic advances for Ca2+ channels are 3-fold. First,
we discover that apoCaM binding to Ca2+ channels strongly
elevates PO by up to 7-fold, before the onset of CDI. At least
2-fold increases of peak current were routinely seen in individual
cells undergoing enrichment of apoCaMby rapamycin (Figure 4),
but this enhancement is likely a lower bound imposed by limita-
tions of apoCaM recruitment via chemical dimerization (Fig-
ure 4B). Usingmodal analysis of single channels (e.g., Figure 2G),
7-fold augmentation of PO can be directly deduced. Additionally,
the quantitative adherence of all variants to a single line in Fig-
ure 5D independently supports this 7-fold PO modulatory range.
That said, the extent of PO regulation by apoCaM rivals the
upregulation of L type Ca2+ channels by adrenergic stimulation
(Miriyala et al., 2008), the prototypic modulatory system for
fight-or-flight responses (Tsien et al., 1986). Second, we unveil
an intimate connection between the modulation of PO and CDI,
where the binding of one and the same apoCaM to channels
brings not only the ability to undergo CDI as previously reportedin HEK cells, with only endogenous CaM.
unitary current i and number of channels N.
ed over multiple patches. Error bars are ± SEM.
(NaV1.4IQ/AA). Channels are coexpressed with the CaM chelator, BSCaMIQ, to
S7.
ear wild-type levels. PO–V relations averaged from n = 5–8 patches each. Error
aV currents for configurations above.
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(Bazzazi et al., 2013; Ben-Johny et al., 2013; Liu et al., 2010) but
also the aforementioned increase of initial PO. Intriguingly, the PO
of channels lacking CaM (Figure 5E, configuration E) seems
equivalent to that of channels that have undergone CDI (config-
uration I); in particular, PE PI 0.051. This outcome is visually
confirmed in Figure 4 by the invariance of steady-state current
after 300 ms depolarization during rapamycin (see exemplar
traces). CDI may thus represent a relinquishing of the initial
apoCaM enhancement of PO. For reference, configurations A
and I in Figure 5E explicitly correspond to proposed molecular
arrangements in a prior publication (respectively, Figures 8b
and 8c in Ben-Johny et al., 2013). Third, the spectrum of PO
and CDI properties of CaV1.3 variants (Figure 1A) can now be
unified by a single molecular effect—customization of channel
binding to apoCaM (Figure 5E). Notably, beyond this specific ef-
fect, the properties of variant channels seem largely equivalent
once apoCaM becomes bound or unbound. This conclusion is
supported by the adherence of all tested variants to a single rela-
tion in Figure 5D. One nuance of this unified viewmay be that the
voltage dependence of activation appears subtly different for a
variant with an extended DCT that lacks apoCaM (Figures 1E,
S1E, and S1F).
The biological implications of thesemechanisms are consider-
able. In particular, the apoCaM affinities of many editing and
splice variants are such that natural fluctuations in ambient
CaM influence the distribution of channels between pools lack-
ing or armed with apoCaM (Bazzazi et al., 2013; Liu et al.,
2010). In switching between pools, we now know that PO and
CDI will be coordinately regulated (Figures 5E and 5F). Further-
more, variants tune not only the midpoint sensitivity to apoCaM
at steady state but also the kinetic response to changes in
apoCaM (cf., Figures 4D, 4E, and 4F), a property now discernible
via CaM step generation. Indeed, it will be important to explore
the sequelae of these distinctive kinetic and steady-state prop-
erties on Ca2+ homeostasis and dysfunction, given CaM varia-
tion in physiological and disease conditions (Bezprozvanny,
2009; Black et al., 2004; Bossuyt and Bers, 2013; Chafouleas
et al., 1982; Ikeda et al., 2009; Lesnick et al., 2007; Yacoubian
et al., 2008). Specifically, given the marked broadening of APs
in substantia nigral neurons (Figure 6), it is tempting to speculate
that elevated apoCaM predisposes for Ca2+-related neurode-
generation in Parkinson’s. Similar modulatory scenarios may
pertain throughout the CaV1-2 superfamily (Ben-Johny and
Yue, 2014), with corresponding biomedical implications. Finally,
the mechanisms revealed here (Figures 5E) sharpen distinctions
between CaM abnormalities relating to Ca2+/CaM versus
apoCaM dysfunction; for example, recently reported CaM
missense mutations associated with long-QT syndrome are
likely to selectively inhibit transitions into configuration I of CaV
channels (in Figure 5E), while allowing normal access to config-
uration A via maintained binding of Ca2+-free mutant CaMs (Lim-
pitikul et al., 2014).
The extension of like mechanisms to other ion-channel fam-
ilies holds the broadest implications. Only recently have Na
channels been shown to exhibit CaM-mediated CDI with simi-
larity to CaV channels (Ben-Johny et al., 2014). This likeness is
now significantly generalized by our finding that apoCaM also
robustly amplifies PO of NaV1.4 (Figure 7). This conserved620 Cell 159, 608–622, October 23, 2014 ª2014 Elsevier Inc.modulation in Na channels then suggests that channelopathic
disease mutations (Lossin, 2009; Schroeter et al., 2010), RNA
editing (Song et al., 2004), and alternative splicing (Lossin,
2009) could all alter apoCaM binding and thereby PO. The con-
sequences may be extensive, as the NaV1.1-1.9 superfamily
governs excitability in brain, heart, and skeletal muscle (Hille,
1984), and related diseases encompass epilepsy, autism, path-
ological pain, cardiac arrhythmias, and skeletal muscle myoto-
nias (Lossin, 2009; Schroeter et al., 2010). More broadly,
numerous other transport molecules bind apoCaM (Bosanac
et al., 2005; Saimi and Kung, 2002; Samso´ and Wagenknecht,
2002; Vocke et al., 2013; Wen and Levitan, 2002; Xia et al.,
1998). Thus, apocalmodulin promises widespread ion-channel
regulation whose scope and stature seem likely to proliferate.
EXPERIMENTAL PROCEDURES
Molecular Biology
CaV1.3S and CaV1.3L are identical to previously published rat CaV1.3D
(AF370009.1) and rat CaV1.3D with human long distal carboxyl tail
(NM000718), respectively (Liu et al., 2010). CaV1.3S editing/splice variants and
apoCaM mutations are the same as those previously published (Bazzazi et al.,
2013; Ben-Johny et al., 2013). Lyn-GFP-FRB construct is the same as previously
published, andYFP-FKBP-CaMwas generated fromYFP-FKBP-PI(4)P5K (Ueno
et al., 2011). Standard cloning andPCR-based strategies for generating CaV var-
iants and FKBP-CaM clones are detailed in Extended Experimental Procedures.
Whole-Cell Electrophysiology
Voltage-clamp and current-clamp whole-cell recording were performed using
an Axopatch 200A amplifier. Data were collected and analyzed using custom
MATLAB software (Mathworks). Details of recording conditions and recipes for
internal and external solutions are specified in Extended Experimental
Procedures.
Single-Channel Electrophysiology
Single-channel recordings were performed in the on-cell configuration, using
established methods from our laboratory (Tay et al., 2012). To reduce noise,
patch pipettes were pulled from ultra-thick-walled borosilicate glass (BF200-
116-10, Sutter Instruments) and coated with Sylgard. Recording conditions,
data analysis, and recipes for internal and external solutions are provided in
Extended Experimental Procedures.
Rapamycin Experiments
Whole-cell currents were recorded for 100 swith regular external solution flow-
ing at 2 ml/min. At 100 s, flow of regular solution was stopped, and flow of the
same external containing 200 nM rapamycin was started, triggering dimeriza-
tion of FRB and FKBP tags that then elevated perimembranous CaM. Flow
rates were carefully matched between lines prior to experiments.
Confocal Optical Imaging
Fluorescence images were captured at 20 s intervals, before and after bath
application of 200 nM rapamycin. Images were recorded with Olympus Fluo-
view FV300 and Zeiss LSM710 laser scanning confocal microscopes. Images
were analyzed using MATLAB and ImageJ. Details of experimental set-up and
data analysis are provided in Extended Experimental Procedures.
SNc Computer Simulation
AP waveforms for substantia nigra dopaminergic neurons were simulated us-
ing MATLAB 2010b (Mathworks) based on published models. Details of the
model are included in Extended Experimental Procedures and Table S2.
SNc DA Neuron Culture
SNc neurons were isolated from mice expressing GFP under the tyrosine hy-
droxylase promoter (TH-GFP) (GENSAT; Rockefeller University) (Gong et al.,
2003). Experimental procedures and solution recipes are included in Extended
Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, seven
figures, and two tables and can be foundwith this article online at http://dx.doi.
org/10.1016/j.cell.2014.09.047.
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